NIFTY 50▲24,205.05
209.70 (0.87%)
SENSEX▲79,461.73
679.49 (0.86%)
NIFTY BANK▲52,151.10
935.85 (1.83%)
TATA MOTORS▲834.80
10.70 (1.30%)
SUZLON ENERGY▲67.25
0.93 (1.40%)
TATA STEEL▲152.40
5.45 (3.71%)
INDIAN RAILWAY FINANCE CORP▼151.31
-1.93 (-1.26%)
TATA POWER▲434.20
5.15 (1.20%)
RAIL VIKAS NIGAM▲450.40
4.20 (0.94%)
RELIANCE INDUSTRIES▲1,307.40
5.25 (0.40%)
VODAFONE IDEA▲8.14
0.26 (3.30%)
ZOMATO▼241.04
-4.04 (-1.65%)
RELIANCE POWER▼41.45
-0.58 (-1.38%)
INDIAN RENEWABLE ENERGY▼204.50
-0.88 (-0.43%)
ADANI POWER▲601.90
16.90 (2.89%)
YES BANK▲20.64
0.31 (1.52%)
STATE BANK OF INDIA▲848.25
18.40 (2.22%)
NHPC▼80.04
-3.26 (-3.91%)
HDFC BANK▲1,755.60
41.50 (2.42%)
OLA ELECTRIC MOBILITY LTD▼74.28
-6.56 (-8.11%)
JIO FIN SERVICES LTD▲321.95
2.10 (0.66%)
INDIAN OIL CORP▲140.74
1.81 (1.30%)
BHARAT ELECTRONICS▲285.60
1.45 (0.51%)
GTL INFRA▲2.21
0.10 (4.74%)
MRF▼1,19,820.00
-1056.75 (-0.87%)
ADANI PORT & SEZ▼1,329.85
-19.40 (-1.44%)
JAIPRAKASH POWER VENTURES▲17.95
0.07 (0.39%)
ITC▼481.00
-3.60 (-0.74%)
REMUS PHARMACEUTICALS L Share Price
REMUS
₹2,540.00-₹2.60 (-0.1%) TodayLast updated on 05 Nov, 2024 | 15:28 IST
REMUS PHARMACEUTICALS L Share Price Chart
Please wait...
Company overview
REMUS PHARMACEUTICALS L Financials
Market cap ₹1,498 Crs | Open ₹2,542.60 | Close ₹2,542.60 |
Circuit range ₹3,051.10 - ₹2,034.10 | Day range ₹2,525.00 - ₹2,550.00 | Year range ₹1,785.10 - ₹8,747.00 |
Volume 1,250 | Avg. traded ₹2,536.21 | Revenue (12m) ₹212 Crs |
REMUS PHARMACEUTICALS LRemus Pharmaceuticals Limited is engaged in marketing and distribution of finished formulations of pharmaceutical drugs. The Company also deals in active pharmaceutical ingredient (API). It also provides technical consultancy services to various distributors for preparation of reports on the dossiers of the products to be registered by them in various countries. It deals in drug forms like capsules, cream, eye drops, gel, infusion, inhalation, inhaler, injection, nail lacquer, nasal solution, nasal spray, nebulizer, ointment, ophthalmic, oral gel, oral solution, oral suspension, sachet, suspension, tablet. The therapeutic areas it works include oncology, cardiovascular, anti-diabetic, immune suppressants, anti-biotic, antibacterial, dermatology, central nervous system, and others. Its oncology products include Sorafenib Tablets, Enzalutamide Capsules, Lenalidomide Capsule, and others. Its cardiovascular products include Rivaroxaban Tablets, Ticagrelor Tablets, and others.
REMUS PHARMACEUTICALS L Key indicators
52 week high ₹8,747.00 | 52 week low ₹1,785.10 | P/E ratio 68.1 |
P/B ratio 16.6 | ROE 33.24% | ROCE 41.31% |
Dividend yield 0.23% | Debt/Equity ratio 0.02 | EPS 114.19 |
Learn more
Featured in
Investment checklist: (3/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
REMUS PHARMACEUTICALS L Fundamentals
REMUS PHARMACEUTICALS L Financial Ratios
Operating profit margin37.38% | Net profit margin26.49% |
ROE33.24% | ROA25.53% |
ROCE41.31% |
Learn more
REMUS PHARMACEUTICALS L Share Price history
Day | Open | Close | Change % |
---|---|---|---|
Mon, Nov 4 2024 | ₹2,625.00 | ₹2,542.60 | -3.41% |
Fri, Nov 1 2024 | ₹2,648.00 | ₹2,632.30 | |
Thu, Oct 31 2024 | ₹2,620.00 | ₹2,616.70 | |
Wed, Oct 30 2024 | ₹2,580.00 | ₹2,598.75 | |
Tue, Oct 29 2024 | ₹2,450.00 | ₹2,571.45 | |
Mon, Oct 28 2024 | ₹2,406.50 | ₹2,441.00 | |
Fri, Oct 25 2024 | ₹2,544.00 | ₹2,404.75 | -1.81% |
Thu, Oct 24 2024 | ₹2,462.00 | ₹2,449.00 | -1.32% |
Events
Corporate actions
Bonus • 3:1
Ex date 06 Jun 2024
Dividend • ₹4/share
Ex date 02 May 2024
Dividend • ₹2/share
Ex date 27 Oct 2023
Dividend • ₹2/share
Ex date 15 Sep 2023
Learn more
More